Related Experiment Video
Updated: Feb 10, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
Published on: June 3, 2016
The Epigenetic Factor KDM2B Regulates EMT and Small GTPases in Colon Tumor Cells
Nefeli Zacharopoulou1, Anna Tsapara1, Galatea Kallergi1
1Department of Biochemistry, University of Crete Medical School, Voutes, Heraklion, Greece.
Background/Aims:
The epigenetic factor KDM2B is a histone demethylase expressed in various tumors. Recently, we have shown that KDM2B regulates actin cytoskeleton organization, small Rho GTPases signaling, cell-cell adhesion and migration of prostate tumor cells. In the present study, we addressed its role in regulating EMT and small GTPases expression in colon tumor cells.
Methods:
We used RT-PCR for the transcriptional analysis of various genes, Western blotting for the assessment of protein expression and immunofluorescence microscopy for visualization of fluorescently labeled proteins.
Results:
We report here that KDM2B regulates EZH2 and BMI1 in HCT116 colon tumor cells. Knockdown of this epigenetic factor induced potent up-regulation of the protein levels of the epithelial markers E-cadherin and ZO-1, while the mesenchymal marker N-cadherin was downregulated. On the other hand, KDM2B overexpression downregulated the levels of both epithelial markers and upregulated the mesenchymal marker, suggesting control of EMT by KDM2B. In addition, RhoA, RhoB and RhoC protein levels diminished upon KDM2B-knockdown, while all three small GTPases became upregulated in KDM2B-overexpressing HCT116 cell clones. Interestingly, Rac1 GTPase level increased upon KDM2B-knockdown and diminished in KDM2B-overexpressing HCT116 colon tumor- and DU-145 prostate cancer cells.
Conclusions:
These results establish a clear functional role of the epigenetic factor KDM2B in the regulation of EMT and small-GTPases expression in colon tumor cells and further support the recently postulated oncogenic role of this histone demethylase in various tumors.
Insights
The epigenetic factor KDM2B regulates epithelial-mesenchymal transition (EMT) and small GTPase expression in colon tumor cells. This histone demethylase plays a role in cancer progression and cell signaling.
Area of Science:
- Oncology
- Epigenetics
- Cell Biology
Background:
- KDM2B is an epigenetic factor and histone demethylase found in various tumors.
- KDM2B influences actin cytoskeleton, Rho GTPases, cell adhesion, and migration in prostate cancer cells.
Purpose of the Study:
- To investigate the role of KDM2B in regulating epithelial-mesenchymal transition (EMT) and small GTPases expression in colon tumor cells.
Main Methods:
- Reverse transcription-polymerase chain reaction (RT-PCR) for gene expression analysis.
- Western blotting for protein level assessment.
- Immunofluorescence microscopy for protein localization.
Main Results:
- KDM2B knockdown in HCT116 cells upregulated epithelial markers (E-cadherin, ZO-1) and downregulated mesenchymal marker (N-cadherin), indicating inhibition of EMT.
- KDM2B overexpression had the opposite effect, promoting EMT.
- KDM2B modulated the protein levels of RhoA, RhoB, RhoC, and Rac1 GTPases in colon and prostate cancer cells.
Conclusions:
- KDM2B plays a significant role in regulating EMT and small GTPase expression in colon tumor cells.
- These findings support the oncogenic role of KDM2B in various cancers.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
The Colonization of Land
Transcription Factors

